Search

Search results

66 results found

Progress in the understanding and utilization of biologic response modifiers in the treatment of uveitis.

Publication: Journal Article

Maleki, Arash, Halea Meese, Haitham Sahawneh, and Stephen Foster. 2016. “Progress in the Understanding and Utilization of Biologic Response Modifiers in the Treatment of Uveitis.”. Expert Rev Clin Immunol 12 (7): 775-86.

Lipoxin A4 activates ALX/FPR2 receptor to regulate conjunctival goblet cell secretion.

Publication: Journal Article

Hodges, Li, Shatos, Bair, Lippestad, Serhan, and Dartt. 2017. “Lipoxin A4 Activates ALX/FPR2 Receptor to Regulate Conjunctival Goblet Cell Secretion.”. Mucosal Immunol 10 (1): 46-57.

Clinical Models and Algorithms for the Prediction of Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology.

Publication: Journal Article

Hutchinson, Amy, Michele Melia, Michael Yang, Deborah VanderVeen, Lorri Wilson, and Scott Lambert. 2016. “Clinical Models and Algorithms for the Prediction of Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology.”. Ophthalmology 123 (4): 804-16.

Diagnosis and management of non-infectious immune-mediated scleritis: current status and future prospects.

Publication: Journal Article

Oray, Merih, Halea Meese, and Stephen Foster. 2016. “Diagnosis and Management of Non-Infectious Immune-Mediated Scleritis: Current Status and Future Prospects.”. Expert Rev Clin Immunol 12 (8): 827-37.

Boston Keratoprosthesis Type 1 in Chemical Burns.

Publication: Journal Article

Salvador-Culla, Borja, Paraskevi Kolovou, Linnette Arzeno, Santiago Martínez, and Miguel López. 2016. “Boston Keratoprosthesis Type 1 in Chemical Burns.”. Cornea 35 (6): 911-6.

Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States.

Publication: Journal Article

Wang, Ye Elaine, Caitlin Kakigi, Diego Barbosa, Travis Porco, Rebecca Chen, Sophia Wang, Yingjie Li, Kuldev Singh, Louis Pasquale, and Shan Lin. 2016. “Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States.”. Ophthalmology 123 (4): 729-36.

Second primary neoplasms in patients with uveal melanoma: a SEER database analysis.

Publication: Journal Article

Laíns, Inês, Carla Bartosch, Vera Mondim, Brian Healy, Ivana Kim, Deeba Husain, and Joan Miller. 2016. “Second Primary Neoplasms in Patients With Uveal Melanoma: A SEER Database Analysis.”. Am J Ophthalmol.

POOR PROGNOSTIC FACTORS IN PATIENTS WITH BIRDSHOT RETINOCHOROIDOPATHY.

Publication: Journal Article

Silpa-Archa, Sukhum, Joan Lee, Sutasinee Boonsopon, Marisol Lizárraga, Janine Preble, Dusit Sujirarat, Pranav Patel, and Stephen Foster. 2016. “POOR PROGNOSTIC FACTORS IN PATIENTS WITH BIRDSHOT RETINOCHOROIDOPATHY.”. Retina 36 (11): 2220-26.

In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery.

Publication: Journal Article

Garanto, Alejandro, Daniel Chung, Lonneke Duijkers, Julio Corral-Serrano, Muriël Messchaert, Ru Xiao, Jean Bennett, Luk Vandenberghe, and Rob Collin. 2016. “In Vitro and in Vivo Rescue of Aberrant Splicing in CEP290-Associated LCA by Antisense Oligonucleotide Delivery.”. Hum Mol Genet.

Statement regarding first in-human clinical trial in inherited retinal degeneration (retinitis pigmentosa)

News: March 28, 2016

Mass. Eye and Ear and the Harvard Medical School Department of Ophthalmology are proud to be leading this important clinical trial. We look forward to reporting on safety and efficacy studies in the months and years to come. ReNeuron announces first patient treated in US Phase I/II clinical trial in...